当前位置:首页 - 行情中心 - 川宁生物(301301) - 财务分析 - 现金流量表

川宁生物

(301301)

  

流通市值:63.88亿  总市值:230.59亿
流通股本:6.18亿   总股本:22.30亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,759,760,332.741,617,175,171.52620,005,079.474,653,467,257.76
  收到的税费返还2,932,581.56-020,662,248.91
  收到其他与经营活动有关的现金64,561,162.1235,719,213.0428,158,410.87108,982,515.72
  经营活动现金流入小计2,827,254,076.421,652,894,384.56648,163,490.344,783,112,022.39
  购买商品、接受劳务支付的现金1,397,070,411.12623,684,186.24199,143,610.831,688,602,393.04
  支付给职工以及为职工支付的现金371,438,880.45266,613,711.34159,333,188.58487,314,482.1
  支付的各项税费462,680,179.51346,751,292.02167,563,156.57669,136,122.55
  支付其他与经营活动有关的现金25,123,340.0324,361,426.565,538,993.84146,991,748.35
  经营活动现金流出小计2,256,312,811.111,261,410,616.16531,578,949.822,992,044,746.04
  经营活动产生的现金流量净额570,941,265.31391,483,768.4116,584,540.521,791,067,276.35
二、投资活动产生的现金流量:
  收回投资收到的现金1,920,903,734.05960,449,358.05200,464,358.91205,506,853.08
  取得投资收益收到的现金1,126,793.431,115,193.43-631,100
  处置固定资产、无形资产和其他长期资产收回的现金净额---46,180.51
  投资活动现金流入小计1,922,030,527.48961,564,551.48200,464,358.91206,184,133.59
  购建固定资产、无形资产和其他长期资产支付的现金62,973,255.6724,203,403.7410,215,903.2942,601,377.78
  投资支付的现金2,161,029,277.78982,360,666.67412,750,000269,800,000
  投资活动现金流出小计2,224,002,533.451,006,564,070.41422,965,903.29312,401,377.78
  投资活动产生的现金流量净额-301,972,005.97-44,999,518.93-222,501,544.38-106,217,244.19
三、筹资活动产生的现金流量:
  吸收投资收到的现金20,135,52012,935,520-26,191,920
  其中:子公司吸收少数股东投资收到的现金7,200,000--5,931,000
  取得借款收到的现金499,989,863.01--780,000,000
  筹资活动现金流入小计520,125,383.0112,935,5200806,191,920
  偿还债务支付的现金510,333,33325,333,33322,333,3331,561,333,333
  分配股利、利润或偿付利息支付的现金618,269,188.56613,781,953.066,418,022.04545,072,524.74
  支付其他与筹资活动有关的现金577,615.2577,615.2-60,855,230.4
  筹资活动现金流出小计1,129,180,136.76639,692,901.2628,751,355.042,167,261,088.14
  筹资活动产生的现金流量净额-609,054,753.75-626,757,381.26-28,751,355.04-1,361,069,168.14
四、汇率变动对现金及现金等价物的影响2,265,910.673,203,527.391,905,343.16,537,247.24
五、现金及现金等价物净增加额-337,819,583.74-277,069,604.4-132,763,015.8330,318,111.26
  加:期初现金及现金等价物余额1,085,404,379.061,085,404,379.061,085,404,379.06758,013,563.35
  期末现金及现金等价物余额747,584,795.32808,334,774.66952,641,363.261,088,331,674.61
补充资料:
  净利润-454,575,661.01-1,400,350,219.97
  资产减值准备-29,236,268.77-10,387,988.59
  固定资产和投资性房地产折旧-273,102,983.68-519,591,217.3
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-273,102,983.68-519,591,217.3
  无形资产摊销-9,732,525.89-22,151,665.61
  长期待摊费用摊销-439,126.5-878,253
  处置固定资产、无形资产和其他长期资产的损失--352,143.38--
  固定资产报废损失-859,508.76-1,247,122.82
  公允价值变动损失--4,354.45--31,500
  财务费用-18,204,971.56-55,373,012.79
  投资损失--501,508.54--358,468.07
  递延所得税--2,940,164.75-460,728.5
  其中:递延所得税资产减少--3,026,396.23-768,004.49
    递延所得税负债增加-86,231.48--307,275.99
  存货的减少-219,184,289.14-317,295,353.6
  经营性应收项目的减少--434,368,262.14--557,510,093.81
  经营性应付项目的增加--184,487,916.05--7,987,519.08
  其他---12,494,626.76
  不涉及现金收支的投资和筹资活动金额其他项目---311,206,323.31
  现金的期末余额-808,334,774.66-1,088,331,674.61
  减:现金的期初余额-1,085,404,379.06-758,013,563.35
  现金及现金等价物的净增加额--277,069,604.4-330,318,111.26
公告日期2025-10-282025-08-262025-04-292025-04-22
审计意见(境内)标准无保留意见
TOP↑